Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89


Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy.

Shackleton L, Langabeer SE, O'Brien D, McCarron SL, Byrne B, Barry R, Flavin R, Bacon CL, Flynn CM.

Case Rep Hematol. 2019 Aug 21;2019:3238168. doi: 10.1155/2019/3238168. eCollection 2019.


Potentially important miRNAs in enteropathy-associated T-cell lymphoma pathogenesis: A pilot study.

Clarke L, Adduri RS, Smyth P, Quinn F, Jeffers M, Dunne B, O'Leary J, McKiernan S, Vandenberghe E, Pyne S, Bashyam MD, Sheils O, Flavin R.

Leuk Res Rep. 2018 Oct 16;10:52-54. doi: 10.1016/j.lrr.2018.10.002. eCollection 2018. No abstract available.


Impact and importance of a centralised review panel for lymphoma diagnostics in the WHO era: a single-centre experience.

Dinneen K, Ryan C, Grant C, Dunne B, Bacon L, Vandenberghe E, Jeffers M, Flavin R.

J Clin Pathol. 2019 Jul;72(7):506-509. doi: 10.1136/jclinpath-2018-205691. Epub 2019 Mar 25.


Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.

Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP).

Carcinogenesis. 2018 Dec 31;39(12):1431-1437. doi: 10.1093/carcin/bgy112.


Composite t(14;18)-Negative Follicular Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

O'Neill JP, Quinn F, Dowling A, Walker J, Hayes T, Bird B, Flavin R.

Case Rep Hematol. 2018 Aug 2;2018:4312594. doi: 10.1155/2018/4312594. eCollection 2018.


Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors.

DuPre NC, Flavin R, Sfanos KS, Unger RH, To S, Gazeeva E, Fiorentino M, De Marzo AM, Rider JR, Mucci LA; Transdisciplinary Prostate Cancer Partnership(ToPCaP).

Prostate. 2018 Nov;78(15):1172-1180. doi: 10.1002/pros.23692. Epub 2018 Jul 15.


FISH studies in DLBCL: correlations with cell of origin: the Irish experience.

Timlin DM, O'Hare K, Walker J, Castriciano G, Connolly Y, Grant C, Bacon CL, Vandenberghe E, Dunne B, Jeffers M, Flavin R.

J Clin Pathol. 2018 Oct;71(10):947-948. doi: 10.1136/jclinpath-2018-205247. Epub 2018 Jun 30. No abstract available.


miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma.

Arts FA, Keogh L, Smyth P, O'Toole S, Ta R, Gleeson N, O'Leary JJ, Flavin R, Sheils O.

Hum Pathol. 2017 Dec;70:98-104. doi: 10.1016/j.humpath.2017.10.008. Epub 2017 Oct 24.


EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline.

Brett FM, Flavin R, Chen D, Loftus T, Looby S, McCarthy A, de Gascun C, Jaffe ES, Nor N, Javadpour M, McCabe D.

Hum Pathol (N Y). 2017 Nov;10:64-68. doi: 10.1016/j.ehpc.2017.06.007.


Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.

Elhassadi E, Flavin R, Browne P, Conneally E, Hayden P, Quinn F, Higgins E, Vandenberghe E.

Ir J Med Sci. 2017 Aug;186(3):589-595. doi: 10.1007/s11845-017-1594-z. Epub 2017 Mar 21.


Perineural Invasion and Risk of Lethal Prostate Cancer.

Zareba P, Flavin R, Isikbay M, Rider JR, Gerke TA, Finn S, Pettersson A, Giunchi F, Unger RH, Tinianow AM, Andersson SO, Andrén O, Fall K, Fiorentino M, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP).

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):719-726. doi: 10.1158/1055-9965.EPI-16-0237. Epub 2017 Jan 6.


Composite Blastoid Variant of Mantle Cell Lymphoma and Classical Hodgkin Lymphoma.

Murray C, Quinn F, Illyes G, Walker J, Castriciano G, O'Sullivan P, Grant C, Vandenberghe E, Bird B, Flavin R.

Int J Surg Pathol. 2017 May;25(3):281-286. doi: 10.1177/1066896916672556. Epub 2016 Oct 7.


NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia.

McGovern B, Quinn F, Andrews C, Jeffers M, Bacon CL, Bird B, Crotty G, Vandenberghe E, Flavin R.

Leuk Lymphoma. 2017 Mar;58(3):732-735. doi: 10.1080/10428194.2016.1211278. Epub 2016 Aug 11. No abstract available.


Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.

Langabeer SE, Haslam K, O'Brien D, Kelly J, Andrews C, Ryan C, Flavin R, Hayden PJ, Bacon CL.

Case Rep Hematol. 2016;2016:6545861. doi: 10.1155/2016/6545861. Epub 2016 Jan 21.


Classical Hodgkin Lymphoma Arising Adjacent to a Breast Implant.

Ryan C, Ged Y, Quinn F, Walker J, Kennedy J, Gillham C, Pittaluga S, McDermott R, Vandenberghe E, Grant C, Flavin R.

Int J Surg Pathol. 2016 Aug;24(5):448-55. doi: 10.1177/1066896916632587. Epub 2016 Feb 16.


Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort.

Thorgeirsson T, Jordahl KM, Flavin R, Epstein MM, Fiorentino M, Andersson SO, Andren O, Rider JR, Mosquera JM, Ingoldsby H, Fall K, Tryggvadottir L, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP).

Carcinogenesis. 2016 Mar;37(3):262-8. doi: 10.1093/carcin/bgw001. Epub 2016 Jan 16.


A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL.

J Natl Cancer Inst. 2015 Nov 27;108(2). pii: djv346. doi: 10.1093/jnci/djv346. Print 2016 Feb.


Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation.

Langabeer SE, Nolan J, Haslam K, Clarke L, Flavin R, Conneally E.

Case Rep Hematol. 2015;2015:703457. doi: 10.1155/2015/703457. Epub 2015 Aug 9.


Case Study: Diffuse Large B-Cell Lymphoma Arising in Ovarian Mature Cystic Teratoma.

Maguire A, Castriciano G, Walker J, Molloy K, Quinn F, Osman N, Vandenberghe E, Jeffers M, Gaffney E, Flavin R.

Int J Gynecol Pathol. 2015 Sep;34(5):459-64. doi: 10.1097/PGP.0000000000000172.


Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangement.

Rafee S, Elamin YY, Joyce E, Toner M, Flavin R, McDermott R, Sheehy N, Hennessy B, O'Byrne K, Gleeson N, Osman N.

Tumori. 2015 Apr 28;101(2):e35-9. doi: 10.5301/tj.5000245.


A novel modification of the Stainsby procedure: surgical technique and clinical outcome.

Concannon E, MacNiocaill R, Flavin R, Kearns S.

Foot Ankle Surg. 2014 Dec;20(4):262-7. doi: 10.1016/j.fas.2014.06.006. Epub 2014 Jul 15.


Development of mapped stress-field boundary conditions based on a Hill-type muscle model.

Cardiff P, Karač A, FitzPatrick D, Flavin R, Ivanković A.

Int J Numer Method Biomed Eng. 2014 Sep;30(9):890-908. doi: 10.1002/cnm.2634. Epub 2014 Apr 7.


SPINK1 protein expression and prostate cancer progression.

Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, Sinnott J, Sweeney C, Sesso HD, Fall K, Giovannucci E, Kantoff P, Stampfer M, Loda M, Mucci LA.

Clin Cancer Res. 2014 Sep 15;20(18):4904-11. doi: 10.1158/1078-0432.CCR-13-1341. Epub 2014 Mar 31.


High-resolution array CGH and gene expression profiling of alveolar soft part sarcoma.

Selvarajah S, Pyne S, Chen E, Sompallae R, Ligon AH, Nielsen GP, Dranoff G, Stack E, Loda M, Flavin R.

Clin Cancer Res. 2014 Mar 15;20(6):1521-30. doi: 10.1158/1078-0432.CCR-13-2090. Epub 2014 Feb 3.


Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.

Pettersson A, Lis RT, Meisner A, Flavin R, Stack EC, Fiorentino M, Finn S, Graff RE, Penney KL, Rider JR, Nuttall EJ, Martin NE, Sesso HD, Pollak M, Stampfer MJ, Kantoff PW, Giovannucci EL, Loda M, Mucci LA.

J Natl Cancer Inst. 2013 Dec 18;105(24):1881-90. doi: 10.1093/jnci/djt332. Epub 2013 Nov 30.


Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer.

Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, Clinton SK, Sesso HD, Giovannucci EL, Stampfer MJ, Loda M, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2354-63. doi: 10.1158/1055-9965.EPI-13-0668. Epub 2013 Oct 15.


FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis.

Levanon K, Sapoznik S, Bahar-Shany K, Brand H, Shapira-Frommer R, Korach J, Hirsch MS, Roh MH, Miron A, Liu JF, Vena N, Ligon AH, Fotheringham S, Bailey D, Flavin RJ, Birrer MJ, Drapkin RI.

Oncogene. 2014 Aug 28;33(35):4424-32. doi: 10.1038/onc.2013.394. Epub 2013 Sep 30.


Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.

Cho J, Chen L, Sangji N, Okabe T, Yonesaka K, Francis JM, Flavin RJ, Johnson W, Kwon J, Yu S, Greulich H, Johnson BE, Eck MJ, Jänne PA, Wong KK, Meyerson M.

Cancer Res. 2013 Nov 15;73(22):6770-9. doi: 10.1158/0008-5472.CAN-13-1145. Epub 2013 Sep 24.


Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study.

Zu K, Martin NE, Fiorentino M, Flavin R, Lis RT, Sinnott JA, Finn S, Penney KL, Ma J, Fazli L, Gleave ME, Bismar TA, Stampfer MJ, Pollak MN, Loda M, Mucci LA, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):1984-93. doi: 10.1158/1055-9965.EPI-13-0349. Epub 2013 Aug 27.


Gleason grade progression is uncommon.

Penney KL, Stampfer MJ, Jahn JL, Sinnott JA, Flavin R, Rider JR, Finn S, Giovannucci E, Sesso HD, Loda M, Mucci LA, Fiorentino M.

Cancer Res. 2013 Aug 15;73(16):5163-8. doi: 10.1158/0008-5472.CAN-13-0427.


Comparison of gait after total ankle arthroplasty and ankle arthrodesis.

Flavin R, Coleman SC, Tenenbaum S, Brodsky JW.

Foot Ankle Int. 2013 Oct;34(10):1340-8. doi: 10.1177/1071100713490675. Epub 2013 May 13.


Development and progress of Ireland's biobank network: Ethical, legal, and social implications (ELSI), standardized documentation, sample and data release, and international perspective.

Mee B, Gaffney E, Glynn SA, Donatello S, Carroll P, Connolly E, Garrigle SM, Boyle T, Flannery D, Sullivan FJ, McCormick P, Griffin M, Muldoon C, Fay J, O'Grady T, Kay E, Eustace J, Burke L, Sheikh AA, Finn S, Flavin R, Giles FJ.

Biopreserv Biobank. 2013 Feb;11(1):3-11. doi: 10.1089/bio.2012.0028. Review.


Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening.

Laios A, Mohamed BM, Kelly L, Flavin R, Finn S, McEvoy L, Gallagher M, Martin C, Sheils O, Ring M, Davies A, Lawson M, Gleeson N, D'Arcy T, d'Adhemar C, Norris L, Langhe R, Saadeh FA, O'Leary JJ, O'Toole SA.

Int J Mol Sci. 2013 Jan 22;14(1):2085-103. doi: 10.3390/ijms14012085.


Use of a geometric formula to improve the radiographic correction achieved by the scarf osteotomy.

O'Briain DE, Flavin R, Kearns SR.

Foot Ankle Int. 2012 Aug;33(8):647-54.


Aortic fistula after neoadjuvant chemoradiotherapy and esophagectomy for esophageal carcinoma: an unusual cause of sudden death.

Egan C, Szontagh-Kishazi P, Flavin R.

Am J Forensic Med Pathol. 2012 Sep;33(3):270-2. doi: 10.1097/PAF.0b013e318252e5e7.


The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.

Pettersson A, Graff RE, Bauer SR, Pitt MJ, Lis RT, Stack EC, Martin NE, Kunz L, Penney KL, Ligon AH, Suppan C, Flavin R, Sesso HD, Rider JR, Sweeney C, Stampfer MJ, Fiorentino M, Kantoff PW, Sanda MG, Giovannucci EL, Ding EL, Loda M, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1497-509. doi: 10.1158/1055-9965.EPI-12-0042. Epub 2012 Jun 26.


MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer.

Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, Marani M, Strano S, Muti P, Blandino G, Loda M.

Cancer Discov. 2012 Mar;2(3):236-47. doi: 10.1158/2159-8290.CD-11-0219. Epub 2012 Jan 5.


Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry.

Fiore C, Bailey D, Conlon N, Wu X, Martin N, Fiorentino M, Finn S, Fall K, Andersson SO, Andren O, Loda M, Flavin R.

J Clin Pathol. 2012 Jun;65(6):496-502. doi: 10.1136/jclinpath-2012-200734. Epub 2012 Mar 23.


Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples.

Gallagher MF, Heffron CC, Laios A, O'Toole SA, Ffrench B, Smyth PC, Flavin RJ, Elbaruni SA, Spillane CD, Martin CM, Sheils OM, O'Leary JJ.

J Ovarian Res. 2012 Jan 19;5(1):2. doi: 10.1186/1757-2215-5-2.


Maintaining Breast Cancer Specimen Integrity and Individual or Simultaneous Extraction of Quality DNA, RNA, and Proteins from Allprotect-Stabilized and Nonstabilized Tissue Samples.

Mee BC, Carroll P, Donatello S, Connolly E, Griffin M, Dunne B, Burke L, Flavin R, Rizkalla H, Ryan C, Hayes B, D'Adhemar C, Banville N, Faheem N, Muldoon C, Gaffney EF.

Biopreserv Biobank. 2011 Dec;9(4):389-398.


Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer.

Dwyer RM, Ryan J, Havelin RJ, Morris JC, Miller BW, Liu Z, Flavin R, O'Flatharta C, Foley MJ, Barrett HH, Murphy JM, Barry FP, O'Brien T, Kerin MJ.

Stem Cells. 2011 Jul;29(7):1149-57. doi: 10.1002/stem.665.


mRNA expression signature of Gleason grade predicts lethal prostate cancer.

Penney KL, Sinnott JA, Fall K, Pawitan Y, Hoshida Y, Kraft P, Stark JR, Fiorentino M, Perner S, Finn S, Calza S, Flavin R, Freedman ML, Setlur S, Sesso HD, Andersson SO, Martin N, Kantoff PW, Johansson JE, Adami HO, Rubin MA, Loda M, Golub TR, Andrén O, Stampfer MJ, Mucci LA.

J Clin Oncol. 2011 Jun 10;29(17):2391-6. doi: 10.1200/JCO.2010.32.6421. Epub 2011 May 2.


Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.

Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, Fiore C, Penney KL, Ma J, Kantoff PW, Stampfer MJ, Loda M, Mucci LA, Giovannucci E.

J Clin Oncol. 2011 Jun 10;29(17):2378-85. doi: 10.1200/JCO.2010.30.9880. Epub 2011 May 2.


β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.

Flavin RJ, Cook J, Fiorentino M, Bailey D, Brown M, Loda MF.

Am J Clin Pathol. 2011 May;135(5):776-82. doi: 10.1309/AJCPPC9EX1ZHMRMA.


RET protein expression in papillary renal cell carcinoma.

Flavin R, Finn SP, Choueiri TK, Ingoldsby H, Ring M, Barrett C, Rogers M, Smyth P, O'Regan E, Gaffney E, O'Leary JJ, Loda M, Signoretti S, Sheils O.

Urol Oncol. 2012 Nov-Dec;30(6):900-5. doi: 10.1016/j.urolonc.2010.08.025. Epub 2011 Mar 10.


Definition of coordinate system for three-dimensional data analysis in the foot and ankle.

Green C, Fitzpatrick C, FitzPatrick D, Stephens M, Quinlan W, Flavin R.

Foot Ankle Int. 2011 Feb;32(2):193-9. doi: 10.3113/FAI.2011.0193.


Metabolic alterations and targeted therapies in prostate cancer.

Flavin R, Zadra G, Loda M.

J Pathol. 2011 Jan;223(2):283-94. doi: 10.1002/path.2809. Epub 2010 Nov 16. Review.


Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.

Pomerantz MM, Shrestha Y, Flavin RJ, Regan MM, Penney KL, Mucci LA, Stampfer MJ, Hunter DJ, Chanock SJ, Schafer EJ, Chan JA, Tabernero J, Baselga J, Richardson AL, Loda M, Oh WK, Kantoff PW, Hahn WC, Freedman ML.

PLoS Genet. 2010 Nov 11;6(11):e1001204. doi: 10.1371/journal.pgen.1001204.


Lateral thigh swelling: an unusual presentation of psoas abscess in a 61-year-old male.

Baker JF, Flavin R, Smyth H.

Ir J Med Sci. 2010 Dec;179(4):609-10. doi: 10.1007/s11845-010-0583-2. Epub 2010 Sep 26.


Occupational problems with microscopy in the pathology laboratory.

Flavin RJ, Guerin M, O'Briain DS.

Virchows Arch. 2010 Oct;457(4):509-11. doi: 10.1007/s00428-010-0965-x. Epub 2010 Aug 31. No abstract available.


Supplemental Content

Loading ...
Support Center